Your browser doesn't support javascript.
loading
Publisher Correction: Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse.
Chemi, Francesca; Rothwell, Dominic G; McGranahan, Nicholas; Gulati, Sakshi; Abbosh, Chris; Pearce, Simon P; Zhou, Cong; Wilson, Gareth A; Jamal-Hanjani, Mariam; Birkbak, Nicolai; Pierce, Jackie; Kim, Chang Sik; Ferdous, Saba; Burt, Deborah J; Slane-Tan, Daniel; Gomes, Fabio; Moore, David; Shah, Rajesh; Al Bakir, Maise; Hiley, Crispin; Veeriah, Selvaraju; Summers, Yvonne; Crosbie, Philip; Ward, Sophia; Mesquita, Barbara; Dynowski, Marek; Biswas, Dhruva; Tugwood, Jonathan; Blackhall, Fiona; Miller, Crispin; Hackshaw, Allan; Brady, Ged; Swanton, Charles; Dive, Caroline.
Afiliação
  • Chemi F; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
  • Rothwell DG; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.
  • McGranahan N; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
  • Gulati S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Abbosh C; University College London Cancer Institute, London, UK.
  • Pearce SP; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Zhou C; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
  • Wilson GA; University College London Cancer Institute, London, UK.
  • Jamal-Hanjani M; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
  • Birkbak N; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
  • Pierce J; University College London Cancer Institute, London, UK.
  • Kim CS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Ferdous S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Burt DJ; University College London Cancer Institute, London, UK.
  • Slane-Tan D; University College London Cancer Institute, London, UK.
  • Gomes F; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Moore D; Department of Molecular Medicine, Aarhus University, Aarhus, Denmark.
  • Shah R; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
  • Al Bakir M; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
  • Hiley C; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
  • Veeriah S; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
  • Summers Y; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
  • Crosbie P; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.
  • Ward S; University College London Cancer Institute, London, UK.
  • Mesquita B; Department of Thoracic Surgery, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
  • Dynowski M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Biswas D; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Tugwood J; University College London Cancer Institute, London, UK.
  • Blackhall F; University College London Cancer Institute, London, UK.
  • Miller C; Division of Cancer Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.
  • Hackshaw A; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.
  • Brady G; Division of Cancer Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.
  • Swanton C; North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
  • Dive C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Nat Med ; 26(7): 1147, 2020 Jul.
Article em En | MEDLINE | ID: mdl-32494064
ABSTRACT
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido